{{Rsnum
|rsid=5742629
|Gene=IGF1
|Chromosome=12
|position=102463485
|Orientation=minus
|GMAF=0.3499
|Gene_s=IGF1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 53.1 | 36.3 | 10.6
| HCB | 30.7 | 52.6 | 16.8
| JPT | 34.5 | 46.9 | 18.6
| YRI | 36.3 | 49.3 | 14.4
| ASW | 26.3 | 49.1 | 24.6
| CHB | 30.7 | 52.6 | 16.8
| CHD | 23.9 | 55.0 | 21.1
| GIH | 54.5 | 40.6 | 5.0
| LWK | 22.7 | 49.1 | 28.2
| MEX | 50.0 | 39.7 | 10.3
| MKK | 41.7 | 48.7 | 9.6
| TSI | 60.8 | 35.3 | 3.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=22509095
|Title=Association of insulin-like growth factor-1 polymorphisms with high myopia in the Chinese population
|OA=1
}}

{{PMID|19252927|OA=1
}} Bladder cancer SNP panel predicts susceptibility and survival.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}